These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21517806)

  • 1. Hypomethylation of PRAME promoter is associated with poor prognosis in myelodysplastic syndrome.
    Qian J; Zhu ZH; Lin J; Ming Yao DM; Li Y; Yang J; Wang CZ
    Br J Haematol; 2011 Jul; 154(1):153-5. PubMed ID: 21517806
    [No Abstract]   [Full Text] [Related]  

  • 2. Aberrant methylation of GTPase regulator associated with the focal adhesion kinase (GRAF) promoter is an adverse prognostic factor in myelodysplastic syndrome.
    Qian J; Qian Z; Lin J; Yao DM; Zhu ZH; Chen Q; Xiao GF; Li JY
    Eur J Haematol; 2010 Aug; 85(2):174-6. PubMed ID: 20374274
    [No Abstract]   [Full Text] [Related]  

  • 3. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.
    Lin J; Wang YL; Qian J; Yao DM; Zhu ZH; Qian Z; Xu WR
    Leuk Res; 2010 Aug; 34(8):991-4. PubMed ID: 20116099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
    Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
    Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p15INK4b methylation correlates with thrombocytopenia, blast percentage, and survival in myelodysplastic syndromes in a dose dependent manner: quantitation using pyrosequencing study.
    Kim M; Oh B; Kim SY; Park HK; Hwang SM; Kim TY; She CJ; Yang I; Yoon SS; Yoon JH; Lee DS
    Leuk Res; 2010 Jun; 34(6):718-22. PubMed ID: 19782398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome.
    Cheng YY; Chau D; Chan T; Gill H; Liang R; Kwong YL; Tse E
    J Clin Pathol; 2010 Nov; 63(11):1008-11. PubMed ID: 20924036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
    Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methylation status of RIZ1 gene promoter in myelodysplastic syndrome].
    Xu RR; Xuan LN; Wang Y
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):774-5. PubMed ID: 23336240
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome.
    Qian J; Yao DM; Lin J; Wang YL; Han LX; Xu WR; Wu CY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):74-81. PubMed ID: 19196380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies.
    Schenk T; Stengel S; Goellner S; Steinbach D; Saluz HP
    Genes Chromosomes Cancer; 2007 Sep; 46(9):796-804. PubMed ID: 17534929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of death-associated protein kinase 1 CpG islands in myelodysplastic syndromes.
    Wu X; Liu W; Tian Y; Xiao M; Wu Y; Li C
    Acta Haematol; 2011; 125(4):179-85. PubMed ID: 21212658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant hypomethylation of DDX43 promoter in myelodysplastic syndrome.
    Chen Q; Lin J; Yao DM; Qian J; Qian W; Yang J; Chai HY; Ma JC; Deng ZQ; Wang CZ; Li Y
    Br J Haematol; 2012 Jul; 158(2):293-296. PubMed ID: 22563673
    [No Abstract]   [Full Text] [Related]  

  • 15. Global increase in DNA methylation in patients with myelodysplastic syndrome.
    Römermann D; Hasemeier B; Metzig K; Göhring G; Schlegelberger B; Länger F; Kreipe H; Lehmann U
    Leukemia; 2008 Oct; 22(10):1954-6. PubMed ID: 18385753
    [No Abstract]   [Full Text] [Related]  

  • 16. High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.
    Liberante FG; Pellagatti A; Boncheva V; Bowen DT; Mills KI; Boultwood J; Guinn BA
    Br J Haematol; 2013 Jul; 162(2):282-5. PubMed ID: 23594062
    [No Abstract]   [Full Text] [Related]  

  • 17. Promoter methylation of P15(INK4B) gene is possibly associated with parvovirus B19 infection in adult acute leukemias.
    Yalcin A; Serin MS; Emekdas G; Tiftik N; Aslan G; Eskandari G; Tezcan S
    Int J Lab Hematol; 2009 Aug; 31(4):407-19. PubMed ID: 18384396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
    Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
    Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGE expressions mediated by demethylation of MAGE promoters induce progression of non-small cell lung cancer.
    Yanagawa N; Tamura G; Oizumi H; Endoh M; Motoyama T
    Anticancer Res; 2011 Jan; 31(1):171-5. PubMed ID: 21273595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.